Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.
Tan SY, Najita J, Li X, Strazzulla LC, Dunbar H, Lee MY, Seery VJ, Buchbinder EI, Tawa NE, McDermott DF, Lee SJ, Atkins MB, Kim CC.
Tan SY, et al. Among authors: strazzulla lc.
Melanoma Res. 2019 Feb;29(1):70-76. doi: 10.1097/CMR.0000000000000483.
Melanoma Res. 2019.
PMID: 30169431